DURAGESIC-37
LOE ApproachingNDATRANSDERMALFILM, EXTENDED RELEASE
Approved
Aug 1990
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DURAGESIC-37 is a transdermal extended-release film formulation approved by the FDA in 1990 for chronic pain management. The product delivers medication continuously through the skin over an extended period, eliminating the need for frequent dosing. Based on the transdermal route and extended-release design, it is likely a potent analgesic targeting opioid-sensitive pain conditions.
LOE Approaching
As LOE approaches, the brand team is likely focused on lifecycle management, cost optimization, and transition planning rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on DURAGESIC-37 offers experience in mature product management, lifecycle optimization, and payer negotiations in a declining commercial environment. This role suits professionals interested in learning defensive marketing strategies and transition planning rather than growth-stage innovation.
Brand ManagerProduct Manager
Worked on DURAGESIC-37 at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.